A detailed history of Premier Path Wealth Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 4,480 shares of AMGN stock, worth $1.3 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
4,480
Previous 4,413 1.52%
Holding current value
$1.3 Million
Previous $1.38 Billion 4.69%
% of portfolio
0.23%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$309.38 - $337.38 $20,728 - $22,604
67 Added 1.52%
4,480 $1.44 Billion
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $183,136 - $222,559
697 Added 18.76%
4,413 $1.38 Billion
Q1 2024

Apr 24, 2024

BUY
$268.87 - $324.56 $6,452 - $7,789
24 Added 0.65%
3,716 $1.06 Billion
Q4 2023

Jan 12, 2024

BUY
$255.7 - $288.46 $944,044 - $1.06 Million
3,692 New
3,692 $1.06 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Premier Path Wealth Partners, LLC Portfolio

Follow Premier Path Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Path Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Path Wealth Partners, LLC with notifications on news.